mayoly spindler committed to your health. every day. · our assets a french company three...

MAYOLY SPINDLER

Committed to your health.

Every day.

2

OUR AMBITION

Become an

international reference

in gastroenterology

and dermo-cosmetics

CONTENTS

OUR ASSETS

A French company

An independent company

An extensive global footprint

25/06/2018PRESENTATION EXCLUSIVELY

FOR OFFICIAL BODIES

3

OUR EMPLOYEES’

COMMITMENT

Our values

A responsible company

OUR FIELDS OF

EXPERTISE

Pharmaceuticals

Dermo-cosmetics

Contract Development &

Manufacturing

OUR ASSETSa French company

▪ Three manufacturing facilities near Paris, 1 in Chatou

(West of Paris) and 2 in Dammarie-les-Lys (East of Paris).

▪ Over 880 employees worldwide, including nearly 610 in

France.

▪ Turnover: €190 million in 2017.

▪ 70% of products sold are made in France.

▪ An economic player contributing to France’s status as one

of the world’s leading pharmaceuticals exporters*.

425/06/2018

PRESENTATION EXCLUSIVELY

FOR OFFICIAL BODIES

* Source: LEEM (French Pharmaceutical Companies Association)– Economic report, 2016 issue.

OUR ASSETSan independent company

▪ Founded in 1909: for more than a century, an

entrepreneurial adventure.

▪ Still an entirely family-owned company.

▪ Financial independence, a main performance driver.

▪ Uninterrupted growth laying the foundations for the

company’s long-term development.

525/06/2018


FOR OFFICIAL BODIES

126138

145154 159 161

167 173

190

0

20

40

60

80

100

120

140

160

180

200

2009 2010 2011 2012 2013 2014 2015 2016 2017

NET CONSOLIDATED TURNOVER

2009-2017 (€ million)

OUR ASSETSan extensive global footprint

▪ Established worldwide in more than 70 countries generating

45% of overall turnover (vs France 55%)

▪ Dynamic subsidiaries: in Europe, Eastern Europe, Asia and

Latin America (32% of international turnover in 2017)

▪ Business partners committed for the long term

▪ A proactive development policy

▪ With the acquisition in 2016 of Kibion, a Swedish company

principally operating in Germany and the Middle East,

Mayoly Spindler has become one of the world leaders in the

detection and control of Helicobacter pylori infections.


FOR OFFICIAL BODIES

6

Subsidiaries

Distributors

OUR FIELDS OF

EXPERTISE

7

PHARMACEUTICALS

8

PHARMACEUTICALSOur historical pillar of development

▪ Pharmaceutical sector: 80% of overall turnover in 2017

▪ Gastroenterology: 70% of our pharmaceutical business.

▪ A portfolio of therapeutic solutions spanning speciality

care, primary care and self-medication.

▪ An investment in collaborative R&D in gastroenterology.

925/06/2018


FOR OFFICIAL BODIES

Pharmaceuticals

€154 million

Dermo-cosmetics

€23 million

CDMO *

€13 million

13 %

7 %

80 %

* Contract Development & Manufacturing Organization

BREAKDOWN OF TURNOVER

BY BUSINESS SECTOR IN 2017

OUR GE THERAPEUTIC SOLUTIONS PORTFOLIO

1025/06/2018


FOR OFFICIAL BODIES

10

Travel sickness

Digestive and renal

elimination functions

Colonoscopy

Pancreatic insufficiency

Cystic fibrosis

Acid reflux

Abdominal pains Crohn’s disease

Constipation

Heartburn

Diagnostic tests

Probiotics / Gut flora

Biliary lithiasis

Biliary cirrhosis

Gaz

DERMO-COSMETICS

11

DERMOCOSMETICSTopicrem, the science of hydration

▪ Ultra-Moisturizing Body Milk

is the n°1 body moisturizer in France*.

▪ High-quality manufacturing standards recognized on an

international level.

▪ All worldwide production of Topicrem is made in France (Dammarie-Les-Lys).

▪ An international brand (50% of Topicrem sales generated

outside of France).

1225/06/2018


FOR OFFICIAL BODIES

* France IMS data Décembre 2016.



Pharmaceuticals

€154 million

Dermo cosmetics

€23 million CDMO *

€13 million

13 % 7 %

80 %


PRODUCTION &

CONTRACT

MANUFACTURING

13

PRODUCTION & CONTRACT MANUFACTURINGTechnical prowess and responsiveness

▪ An agile structure offering our customers a wide range of

possibilities that meet their requirements in pharmaceuticals,

nutraceuticals and dermo-cosmetics

▪ A diversified offer: softgel capsules, tablets, capsules,

syrups, creams…

▪ A softgel capsules expertise requiring a particular

technicality.

▪ They trust us:


FOR OFFICIAL BODIES



14

Pharmaceuticals

€154 million

Dermo cosmetics

€23 million

CDMO *

€13 million

13 %

7 %

80 %


OUR EMPLOYEES’

COMMITMENT,

CENTRAL TO OUR

SUCCESS

15

OUR VALUES


FOR OFFICIAL BODIES

16

Our performance is the result of the talent of our employees who, every day, share ambitious projects and a test for challenge.

Our corporate culture is reflected in the empowerment of our teams, the opportunity to take initiatives and the pragmatism of each individual.

Mayoly Spindler is a company where respect goes hand-in-hand with growth, fostering the well-being of everyone.

RESPONSIBILITY RESPECT PRAGMATISM

A RESPONSIBLE COMPANY

▪ OUR MAYOLY, our corporate responsibility programme.

▪ Three priorities: workplace well-being, commitment to the

community and care for the environment.

▪ Projects designed and coordinated by employees,

working in the general interest.


FOR OFFICIAL BODIES

17

MAYOLY

SPINDLER

AT A GLANCE

18

45%of turnover generated

outside of France.

19

3 production sitesnear Paris: 1 in Chatou

and 2 in Dammarie-les-lys

€190 million turnoverPharmaceuticals: 80%

Dermo-cosmetics: 13%

Production: 7%

Over 880employees worldwide,

including 610 in France.

Figures as at 31/12/2017.

Committed to your health.

Every day.

mayoly spindler committed to your health. every day. · our assets a french company three...

Documents